Published in Neurology on May 01, 1979
Ca2+ channels as targets of neurological disease: Lambert-Eaton Syndrome and other Ca2+ channelopathies. J Bioenerg Biomembr (2003) 0.87
Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res (2001) 0.86
Cancer-associated myasthenic (Eaton-Lambert) syndrome: distribution of abnormality and effect of treatment. J Neurol Neurosurg Psychiatry (1984) 0.78
Abnormalities of autonomic function in the Lambert Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1988) 0.78
Circulating T cell subsets in the Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry (1985) 0.75
Paraneoplastic syndromes of the nervous system. West J Med (1985) 0.75
Early stroke treatment associated with better outcome: the NINDS rt-PA stroke study. Neurology (2000) 4.13
Linkage analysis of neurofibromatosis (von Recklinghausen disease). J Med Genet (1983) 2.13
Myasthenia gravis: a serum factor blocking acetylcholine receptors of the human neuromuscular junction. Lancet (1975) 1.84
Detection of B-mode polarization in the cosmic microwave background with data from the South Pole Telescope. Phys Rev Lett (2013) 1.48
Studies in myasthenia gravis: early thymectomy. Electrophysiologic and pathologic correlations. Am J Med (1975) 1.36
Chronic GM2 gangliosidosis masquerading as atypical Friedreich ataxia: clinical, morphologic, and biochemical studies of nine cases. Neurology (1981) 1.18
Human immunodeficiency virus-associated myopathy: analysis of 11 patients. Ann Neurol (1988) 1.10
A missense mutation in the desmin rod domain is associated with autosomal dominant distal myopathy, and exerts a dominant negative effect on filament formation. Hum Mol Genet (1999) 1.07
Isolated facial numbness. Clinical significance and relation to trigeminal neuropathy. Ann Intern Med (1974) 1.05
Iatrogenic causalgia. Classification, clinical findings, and legal ramifications. Arch Neurol (1984) 1.03
Thymectomy in myasthenia gravis: pathologic, clinical, and electrophysiologic correlations. Ann N Y Acad Sci (1976) 0.95
Ischemia and sensory nerve conduction in diabetes mellitus. Neurology (1979) 0.94
Acetylcholine receptor antibodies in myasthenia gravis. Muscle Nerve (1981) 0.91
Brachial plexus injuries with causalgia resulting from transaxillary rib resection. Arch Surg (1985) 0.91
Antibodies to nucleic acids in myasthenia gravis. Int Arch Allergy Appl Immunol (1976) 0.91
Extrajunctional acetylcholine receptors. Alterations in human and experimental neuromuscular diseases. Arch Neurol (1976) 0.91
Methioninemia and myopathy: a new disorder. Ann Neurol (1981) 0.91
Neurofibromatosis. A review of the clinical problem. Ann N Y Acad Sci (1986) 0.89
The regional curare test and electrophysiologic diagnosis of myasthenia gravis: further studies. Muscle Nerve (1987) 0.89
Nerve growth factor receptors on dissociated neurofibroma Schwann-like cells. Cancer Res (1986) 0.89
Mitochondrial neurogastrointestinal encephalomyopathy syndrome maps to chromosome 22q13.32-qter. Am J Hum Genet (1998) 0.88
Histochemistry and acetylcholine receptor distribution in normal and denervated monkey extraocular muscles. Neurology (1978) 0.87
Autonomic neuropathy associated with autoimmune disease. Neurology (1985) 0.87
Amaurosis fugax associated with ophthalmic artery stenosis: clinical simulation of carotid artery disease. Stroke (1980) 0.86
Schwann-like cells cultured from human dermal neurofibromas. Immunohistological identification and response to Schwann cell mitogens. Ann N Y Acad Sci (1986) 0.86
Hypokalemic periodic paralysis exacerbated by acetazolamide. Neurology (1981) 0.84
Thymectomy in patients more than forty years of age with myasthenia gravis. Surg Gynecol Obstet (1978) 0.84
Tissue culture studies of neurofibromatosis: effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells. Ann Neurol (1985) 0.83
Ocular ergotamine tartrate toxicity during treatment of Vacor-induced orthostatic hypotension. Am J Ophthalmol (1981) 0.83
Nemaline (rod) myopathy: the need for histochemical evaluation of affected families. Ann Neurol (1978) 0.82
The association of carcinoembryonic antigen and peripheral lymphocytes. Surgery (1975) 0.82
Muscle phosphofructokinase deficiency. Biochemical and immunological studies of phosphofructokinase isozymes in muscle culture. J Clin Invest (1983) 0.82
Immunoperoxidase localization of alpha bungarotoxin: a new approach to myasthenia gravis. Ann N Y Acad Sci (1976) 0.82
Regional curare test in evaluation of ocular myasthenia. Arch Neurol (1975) 0.81
Peripheral catecholamine depletion in amyloid autonomic neuropathy. Mt Sinai J Med (1979) 0.81
Neurological aspects of neurofibromatosis. Adv Neurol (1981) 0.81
Orthostatic hypotension in the Holmes-Adie syndrome. Mt Sinai J Med (1980) 0.80
Human immunodeficiency virus wasting syndrome may represent a treatable myopathy. Neurology (1990) 0.80
Acute hypokalemic myopathy in alcoholism. A clinical entity. Arch Neurol (1977) 0.80
Advances in neurofibromatosis 2 (NF2): a workshop report. J Neurogenet (2000) 0.80
Myasthenia gravis unmasked by antiarrhythmic agents. Mt Sinai J Med (1976) 0.80
Plasmapheresis in refractory generalized myasthenia gravis. Arch Neurol (1981) 0.79
A sequential study of denervation - ultrastructural immunoperoxidase localization of alpha-bungarotoxin. Trans Am Neurol Assoc (1975) 0.78
Clinical experience in more than 2000 patients with myasthenia gravis. Ann N Y Acad Sci (1987) 0.78
The acetylcholine receptor in normal and pathologic states. Immunoperoxidase visualization of alpha-bungarotoxin binding at a light and electron-microscopic level. Neurology (1976) 0.78
Evoked responses of the elbow flexors in control subjects and in myopathy patients. Muscle Nerve (1980) 0.78
Steroid therapy in myasthenia gravis associated with thymoma. Mt Sinai J Med (1978) 0.78
Acetylcholine receptors of aneurally cultured human and animal muscle. Neurology (1977) 0.77
A puzzling case of periodic paralysis. Muscle Nerve (1996) 0.77
Linkage of hereditary distal myopathy with desmin accumulation to 2q. Hum Hered (2000) 0.77
Ultrastructural demonstration and analytical application of extrajunctional receptors of denervated human and rat skeletal muscle fibres. Nature (1975) 0.77
Muscle fiber hypotrophy with intact neuromuscular junctions. A study of a patient with congenital neuromuscular disease and ophthalmoplegia. Neurology (1977) 0.77
Nerve growth factor binding to cells derived from neurofibromas. Ann N Y Acad Sci (1986) 0.77
Patterns of daytime sleepiness in narcoleptics and normals: a pupillometric study. Electroencephalogr Clin Neurophysiol (1984) 0.77
Thymomas in patients with myasthenia gravis. Ann Surg (1978) 0.76
Isaacs' syndrome with muscle hypertrophy reversed by phenytoin therapy. Arch Neurol (1983) 0.76
Ganglioside (Cronassial) therapy in diabetic neuropathy. Adv Exp Med Biol (1984) 0.76
The influence of the stimulus on normal sural nerve conduction velocity: a study of the latency of activation. Muscle Nerve (1992) 0.76
Plasmapheresis in myasthenia gravis: controlled study. Lancet (1979) 0.76
Hemifacial spasm and facial myokymia: electrophysiological findings. Muscle Nerve (1987) 0.75
A new regional curare test of the elbow flexors in myasthenia gravis. Muscle Nerve (1980) 0.75
Criteria for the diagnosis of peripheral neuropathies. Occup Environ Med (2002) 0.75
Clinical neurophysiology training and certification in the United States: 2000. Neurology (2001) 0.75
Familial hemiplegic migraine and its abortive therapy with intravenous verapamil. Neurology (2001) 0.75
Adult onset autonomic dysfunction coexistent with familial dysautonomia in a consanguineous family. Neurology (1977) 0.75
Pyridostigmine levels in myasthenia gravis. Neurology (1977) 0.75
Polyneuropathy, papilledema, and plasmacytoma. Mt Sinai J Med (1982) 0.75
Letter: HL-A antigens in myasthenia gravis. Lancet (1974) 0.75
American Association of Electrodiagnostic Medicine guidelines for outcome studies in electrodiagnostic medicine. Muscle Nerve (1996) 0.75
Frequency multiplexed superconducting quantum interference device readout of large bolometer arrays for cosmic microwave background measurements. Rev Sci Instrum (2012) 0.75
The efficacy of oral tolbutamide in chronic alcoholics. Am J Med Sci (1972) 0.75
Alcoholic myopathy. N Engl J Med (1979) 0.75
The pupil in familial dysautonomia. Neurology (1981) 0.75
Extrajunctional acetylcholine receptors on myogenously de=innervated muscle fibers. J Histochem Cytochem (1976) 0.75
Light-cored dense particles in mitochondria of a patient with skeletal muscle and myocardial disease. J Neuropathol Exp Neurol (1976) 0.75
Monoclonal antibodies against mouse nerve growth factor produced by somatic cell hybrids. J Neurosci Res (1981) 0.75
Congenital Horner's syndrome does not alter Lisch nodule formation. Ann Neurol (1994) 0.75
Phakomatoses in reproductive medicine. Mt Sinai J Med (1980) 0.75
Ganglioside therapy in diabetic neuropathy. Muscle Nerve (1986) 0.75
Diabetes control and neuropathy. Ann Intern Med (1981) 0.75
Electrophysiologic diagnosis of myasthenia gravis and the regional curare test. Neurology (1976) 0.75
Invited article: millimeter-wave bolometer array receiver for the Atacama pathfinder experiment Sunyaev-Zel'dovich (APEX-SZ) instrument. Rev Sci Instrum (2011) 0.75
Myasthenia gravis: association with chronic lymphocytic leukemia. N Y State J Med (1977) 0.75
Thymectomy for myasthenia gravis. N Engl J Med (1978) 0.75
Repair of postoperative cerebrospinal fluid leak following radiation and laminectomy: a case report. Mt Sinai J Med (1978) 0.75
Neurotransmitter analysis of dermal neurofibromas: implications for the pathogenesis and treatment of neurofibromatosis. Neurology (1981) 0.75
Acute autonomic neuropathy. Int J Neurol (1981) 0.75
Neurofibromatosis: 1977-1987. Conn Med (1987) 0.75
Peripheral nerve responses during ischemia in the evaluation of diabetic neuropathy. Muscle Nerve (1987) 0.75
Neurophysiology. N Y State J Med (1982) 0.75
Problems in diagnosing neurofibromatosis. Adv Neurol (1981) 0.75
Electrophysiologic evaluations of thymectomy in myasthenia gravis. Preliminary findings. Neurology (1976) 0.75
Case report: Thymectomy-induced remission of acquired autoimmune hemolytic anemia in an adult with myasthenia gravis. Am J Med Sci (1979) 0.75
Prolonged response to edrophonium in myasthenia gravis. Trans Am Neurol Assoc (1975) 0.75
Letter: Myasthenia gravis: relationship between serum factor blocking acetylcholine receptors and anti-striated-muscle antibody. Lancet (1975) 0.75